194 related articles for article (PubMed ID: 30264435)
1. Protective role of c-Jun N-terminal kinase-2 (JNK2) in ibuprofen-induced acute liver injury.
Zoubek ME; Woitok MM; Sydor S; Nelson LJ; Bechmann LP; Lucena MI; Andrade RJ; Bast A; Koek GH; Trautwein C; Cubero FJ
J Pathol; 2019 Jan; 247(1):110-122. PubMed ID: 30264435
[TBL] [Abstract][Full Text] [Related]
2. Combined Activities of JNK1 and JNK2 in Hepatocytes Protect Against Toxic Liver Injury.
Cubero FJ; Zoubek ME; Hu W; Peng J; Zhao G; Nevzorova YA; Al Masaoudi M; Bechmann LP; Boekschoten MV; Muller M; Preisinger C; Gassler N; Canbay AE; Luedde T; Davis RJ; Liedtke C; Trautwein C
Gastroenterology; 2016 Apr; 150(4):968-81. PubMed ID: 26708719
[TBL] [Abstract][Full Text] [Related]
3. Antiapoptotic effect of c-Jun N-terminal Kinase-1 through Mcl-1 stabilization in TNF-induced hepatocyte apoptosis.
Kodama Y; Taura K; Miura K; Schnabl B; Osawa Y; Brenner DA
Gastroenterology; 2009 Apr; 136(4):1423-34. PubMed ID: 19249395
[TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor-induced toxic liver injury results from JNK2-dependent activation of caspase-8 and the mitochondrial death pathway.
Wang Y; Singh R; Lefkowitch JH; Rigoli RM; Czaja MJ
J Biol Chem; 2006 Jun; 281(22):15258-67. PubMed ID: 16571730
[TBL] [Abstract][Full Text] [Related]
5. Increased hepatic fibrosis and JNK2-dependent liver injury in mice exhibiting hepatocyte-specific deletion of cFLIP.
Schattenberg JM; Nagel M; Kim YO; Kohl T; Wörns MA; Zimmermann T; Schad A; Longerich T; Schuppan D; He YW; Galle PR; Schuchmann M
Am J Physiol Gastrointest Liver Physiol; 2012 Aug; 303(4):G498-506. PubMed ID: 22700824
[TBL] [Abstract][Full Text] [Related]
6. Deletion of apoptosis signal-regulating kinase 1 attenuates acetaminophen-induced liver injury by inhibiting c-Jun N-terminal kinase activation.
Nakagawa H; Maeda S; Hikiba Y; Ohmae T; Shibata W; Yanai A; Sakamoto K; Ogura K; Noguchi T; Karin M; Ichijo H; Omata M
Gastroenterology; 2008 Oct; 135(4):1311-21. PubMed ID: 18700144
[TBL] [Abstract][Full Text] [Related]
7. Hepatotoxicity mediated by pyrazole (cytochrome P450 2E1) plus tumor necrosis factor alpha treatment occurs in c-Jun N-terminal kinase 2-/- but not in c-Jun N-terminal kinase 1-/- mice.
Wang X; Wu D; Yang L; Cederbaum AI
Hepatology; 2011 Nov; 54(5):1753-66. PubMed ID: 21748763
[TBL] [Abstract][Full Text] [Related]
8. Loss of c-Jun N-terminal Kinase 1 and 2 Function in Liver Epithelial Cells Triggers Biliary Hyperproliferation Resembling Cholangiocarcinoma.
Cubero FJ; Mohamed MR; Woitok MM; Zhao G; Hatting M; Nevzorova YA; Chen C; Haybaeck J; de Bruin A; Avila MA; Boekschoten MV; Davis RJ; Trautwein C
Hepatol Commun; 2020 Jun; 4(6):834-851. PubMed ID: 32490320
[TBL] [Abstract][Full Text] [Related]
9. Critical role of c-jun (NH2) terminal kinase in paracetamol- induced acute liver failure.
Henderson NC; Pollock KJ; Frew J; Mackinnon AC; Flavell RA; Davis RJ; Sethi T; Simpson KJ
Gut; 2007 Jul; 56(7):982-90. PubMed ID: 17185352
[TBL] [Abstract][Full Text] [Related]
10. c-Jun N-terminal kinase-1 from hematopoietic cells mediates progression from hepatic steatosis to steatohepatitis and fibrosis in mice.
Kodama Y; Kisseleva T; Iwaisako K; Miura K; Taura K; De Minicis S; Osterreicher CH; Schnabl B; Seki E; Brenner DA
Gastroenterology; 2009 Oct; 137(4):1467-1477.e5. PubMed ID: 19549522
[TBL] [Abstract][Full Text] [Related]
11. c-Jun N-terminal protein kinase 1 (JNK1), but not JNK2, is essential for tumor necrosis factor alpha-induced c-Jun kinase activation and apoptosis.
Liu J; Minemoto Y; Lin A
Mol Cell Biol; 2004 Dec; 24(24):10844-56. PubMed ID: 15572687
[TBL] [Abstract][Full Text] [Related]
12. c-Jun N-terminal kinase 1 is deleterious to the function and survival of murine pancreatic islets.
Varona-Santos JL; Pileggi A; Molano RD; Sanabria NY; Ijaz A; Atsushi M; Ichii H; Pastori RL; Inverardi L; Ricordi C; Fornoni A
Diabetologia; 2008 Dec; 51(12):2271-80. PubMed ID: 18853132
[TBL] [Abstract][Full Text] [Related]
13. Isoform-specific functions of c-Jun N-terminal kinase 1 and 2 in lung ischemia-reperfusion injury through the c-Jun/activator protein-1 pathway.
Tan J; Gao W; Yang W; Zeng X; Wang L; Cui X
J Thorac Cardiovasc Surg; 2021 Aug; 162(2):e143-e156. PubMed ID: 32414595
[TBL] [Abstract][Full Text] [Related]
14. JNKs protect from cholestatic liver disease progression by modulating Apelin signalling.
Mohamed MR; Haybaeck J; Wu H; Su H; Bartneck M; Lin C; Boekschoten MV; Boor P; Goeppert B; Rupp C; Strnad P; Davis RJ; Cubero FJ; Trautwein C
JHEP Rep; 2023 Nov; 5(11):100854. PubMed ID: 37791376
[TBL] [Abstract][Full Text] [Related]
15. Involvement of the c-jun N-terminal kinases JNK1 and JNK2 in complement-mediated cell death.
Gancz D; Donin N; Fishelson Z
Mol Immunol; 2009 Dec; 47(2-3):310-7. PubMed ID: 19864026
[TBL] [Abstract][Full Text] [Related]
16. c-Jun N-terminal kinase plays a major role in murine acetaminophen hepatotoxicity.
Gunawan BK; Liu ZX; Han D; Hanawa N; Gaarde WA; Kaplowitz N
Gastroenterology; 2006 Jul; 131(1):165-78. PubMed ID: 16831600
[TBL] [Abstract][Full Text] [Related]
17. Hepatocyte free cholesterol lipotoxicity results from JNK1-mediated mitochondrial injury and is HMGB1 and TLR4-dependent.
Gan LT; Van Rooyen DM; Koina ME; McCuskey RS; Teoh NC; Farrell GC
J Hepatol; 2014 Dec; 61(6):1376-84. PubMed ID: 25064435
[TBL] [Abstract][Full Text] [Related]
18. Redundant roles for cJun-N-terminal kinase 1 and 2 in interleukin-1beta-mediated reduction and modification of murine hepatic nuclear retinoid X receptor alpha.
Kosters A; White DD; Sun H; Thevananther S; Karpen SJ
J Hepatol; 2009 Nov; 51(5):898-908. PubMed ID: 19767119
[TBL] [Abstract][Full Text] [Related]
19. Haematopoietic cell-derived Jnk1 is crucial for chronic inflammation and carcinogenesis in an experimental model of liver injury.
Cubero FJ; Zhao G; Nevzorova YA; Hatting M; Al Masaoudi M; Verdier J; Peng J; Schaefer FM; Hermanns N; Boekschoten MV; Grouls C; Gassler N; Kiessling F; Muller M; Davis RJ; Liedtke C; Trautwein C
J Hepatol; 2015 Jan; 62(1):140-9. PubMed ID: 25173965
[TBL] [Abstract][Full Text] [Related]
20. Jnk1 Deficiency in Hematopoietic Cells Suppresses Macrophage Apoptosis and Increases Atherosclerosis in Low-Density Lipoprotein Receptor Null Mice.
Babaev VR; Yeung M; Erbay E; Ding L; Zhang Y; May JM; Fazio S; Hotamisligil GS; Linton MF
Arterioscler Thromb Vasc Biol; 2016 Jun; 36(6):1122-31. PubMed ID: 27102962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
